SuZhou, China

Xin Dong

This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: AI Speech Co., Ltd., Suzhou Neologics Bioscience Co., Ltd., Yikon Genomics (Suzhou) Co., Ltd.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Dong. Retrieved from https://idiyas.com/inventor/xin-dong-ex7w8cl9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 6.7

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Xin Dong in Cancer Treatment

Introduction

Xin Dong is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. His work focuses on developing innovative solutions that can potentially improve patient outcomes.

Latest Patents

Xin Dong holds a patent for "TIM-3-targeting antibodies and uses thereof." This patent discloses anti-TIM-3 antibodies and antigen-binding fragments, along with polynucleotides encoding these antibodies. The patent also includes pharmaceutical compositions that comprise the antibodies and antigen-binding fragments. The uses of these anti-TIM-3 antibodies in cancer treatment are a key aspect of his invention.

Career Highlights

Xin Dong is associated with Suzhou Neologics Bioscience Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in therapeutic settings, particularly in oncology.

Collaborations

Xin Dong collaborates with talented individuals in his field, including Jinyu Dong and Binbin Wang. These collaborations enhance the innovative capacity of his research and contribute to the development of effective cancer treatments.

Conclusion

Xin Dong's contributions to the field of cancer treatment through his innovative patents highlight the importance of research in biotechnology. His work exemplifies the potential of targeted therapies in improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…